Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1657)	11/10/1998 10:02:00 PM
From: Rudy Saucillo	Read Replies (3) \| Respond to of 2742

A buyer of the company would have to pay book value plus whatever premium Cistron could negotiate. This is irrespective of the market value of the stock. I think 60 cents is reasonable; 75 cents is probably high. $1.00 at the present is, IMO, dreaming. Rudy

To: Dr. John M. de Castro who wrote (1657)	11/10/1998 10:05:00 PM
From: Sidney Reilly	Read Replies (1) \| Respond to of 2742

I've been watching CIST a long time. The only penny companies that do well and sustain a good stock valuation are the ones that have product and revenue. CIST has been too long without producing this. They have cash and apparently according to some here knowledgeable about boi-tech they have a marketable patent (or two?). But their management only knows how to draw salary and spread around the wealth from the lawsuit settlement. It seems they don't know how to make a successful company. With all the penny companies around that have nothing going for them it's a shame to see one with cash and potential languish because of bad management.